Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Breast Cancer

  Free Subscription


Articles published in JAMA

Retrieve available abstracts of 22 articles:
HTML format
Text format



Single Articles


    April 2017
  1. HIMELSTEIN AL, Loprinzi CL, Shapiro CL
    Zoledronic Acid Dosing Interval for Metastatic Cancer-Reply.
    JAMA. 2017;317:1478.
    PubMed     Text format    


    February 2017
  2. SACKEIM MG
    Eradicating a Genetic Mutation.
    JAMA. 2017;317:809.
    PubMed     Text format    


  3. ALLEN D
    Moving the Needle on Recovery From Breast Cancer: The Healing Role of Postmastectomy Tattoos.
    JAMA. 2017;317:672-674.
    PubMed     Text format    


  4. RUGO HS, Klein P, Melin SA, Hurvitz SA, et al
    Association Between Use of a Scalp Cooling Device and Alopecia After Chemotherapy for Breast Cancer.
    JAMA. 2017;317:606-614.
    PubMed     Text format     Abstract available


  5. NANGIA J, Wang T, Osborne C, Niravath P, et al
    Effect of a Scalp Cooling Device on Alopecia in Women Undergoing Chemotherapy for Breast Cancer: The SCALP Randomized Clinical Trial.
    JAMA. 2017;317:596-605.
    PubMed     Text format     Abstract available


  6. HERSHMAN DL
    Scalp Cooling to Prevent Chemotherapy-Induced Alopecia: The Time Has Come.
    JAMA. 2017;317:587-588.
    PubMed     Text format    


  7. MUTH CC
    Chemotherapy and Hair Loss.
    JAMA. 2017;317:656.
    PubMed     Text format    


  8. KURIAN AW, Griffith KA, Hamilton AS, Ward KC, et al
    Genetic Testing and Counseling Among Patients With Newly Diagnosed Breast Cancer .
    JAMA. 2017;317:531-534.
    PubMed     Text format    


    January 2017
  9. BRAGG F, Holmes MV, Iona A, Guo Y, et al
    Association Between Diabetes and Cause-Specific Mortality in Rural and Urban Areas of China.
    JAMA. 2017;317:280-289.
    PubMed     Text format     Abstract available


  10. HIMELSTEIN AL, Foster JC, Khatcheressian JL, Roberts JD, et al
    Effect of Longer-Interval vs Standard Dosing of Zoledronic Acid on Skeletal Events in Patients With Bone Metastases: A Randomized Clinical Trial.
    JAMA. 2017;317:48-58.
    PubMed     Text format     Abstract available


    December 2016
  11. BURSTEIN HJ, Schrag D
    Biosimilar Therapy for ERBB2 (HER2)-Positive Breast Cancer: Close Enough?
    JAMA. 2016 Dec 1. doi: 10.1001/jama.2016.18979.
    PubMed     Text format    


  12. RUGO HS, Barve A, Waller CF, Hernandez-Bronchud M, et al
    Effect of a Proposed Trastuzumab Biosimilar Compared With Trastuzumab on Overall Response Rate in Patients With ERBB2 (HER2)-Positive Metastatic Breast Cancer: A Randomized Clinical Trial.
    JAMA. 2016 Dec 1. doi: 10.1001/jama.2016.18305.
    PubMed     Text format     Abstract available


    November 2016
  13. ABBASI J
    The Nurses' Health Study Takes Fresh Aim at Breast Cancer as It Heads Into Decade Five.
    JAMA. 2016 Nov 23. doi: 10.1001/jama.2016.15976.
    PubMed     Text format    


  14. FOUKAKIS T, von Minckwitz G, Bengtsson NO, Brandberg Y, et al
    Effect of Tailored Dose-Dense Chemotherapy vs Standard 3-Weekly Adjuvant Chemotherapy on Recurrence-Free Survival Among Women With High-Risk Early Breast Cancer: A Randomized Clinical Trial.
    JAMA. 2016;316:1888-1896.
    PubMed     Text format     Abstract available


    October 2016
  15. SLOMSKI A
    Tumor Gene Testing May Help Guide Breast Cancer Treatment Decisions.
    JAMA. 2016;316:1637.
    PubMed     Text format    


  16. VAN DEN BELT-DUSEBOUT AW, van Leeuwen FE, Burger CW
    Breast Cancer Risk After Ovarian Stimulation for In Vitro Fertilization-Reply.
    JAMA. 2016;316:1713-1714.
    PubMed     Text format    


  17. TOMAO F, Papa A, Tomao S
    Breast Cancer Risk After Ovarian Stimulation for In Vitro Fertilization.
    JAMA. 2016;316:1713.
    PubMed     Text format    


    July 2016
  18. VAN DEN BELT-DUSEBOUT AW, Spaan M, Lambalk CB, Kortman M, et al
    Ovarian Stimulation for In Vitro Fertilization and Long-term Risk of Breast Cancer.
    JAMA. 2016;316:300-12.
    PubMed     Text format     Abstract available


    May 2016
  19. CORLEY DA, Haas JS, Kobrin S
    Reducing Variation in the "Standard of Care" for Cancer Screening: Recommendations From the PROSPR Consortium.
    JAMA. 2016;315:2067-8.
    PubMed     Text format    


  20. TAYLOR-PHILLIPS S, Wallis MG, Jenkinson D, Adekanmbi V, et al
    Effect of Using the Same vs Different Order for Second Readings of Screening Mammograms on Rates of Breast Cancer Detection: A Randomized Clinical Trial.
    JAMA. 2016;315:1956-65.
    PubMed     Text format     Abstract available


  21. BURNSIDE ES, Sickles EA, Duffy SW
    A Pragmatic Approach to Determine Components of Optimal Screening Mammography Practice.
    JAMA. 2016;315:1951-3.
    PubMed     Text format    


    April 2016
  22. KRESSIN NR, Gunn CM, Battaglia TA
    Content, Readability, and Understandability of Dense Breast Notifications by State.
    JAMA. 2016;315:1786-8.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: